Annual ROE
-125.46%
+263.11%+67.71%
31 December 2023
Summary:
Adial Pharmaceuticals annual return on equity is currently -125.46%, with the most recent change of +263.11% (+67.71%) on 31 December 2023. During the last 3 years, it has risen by +147.81% (+54.09%). ADIL annual ROE is now -130.90% below its all-time high of 405.99%, reached on 31 December 2016.ADIL ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROE
-256.26%
+34.81%+11.96%
30 September 2024
Summary:
Adial Pharmaceuticals quarterly return on equity is currently -256.26%, with the most recent change of +34.81% (+11.96%) on 30 September 2024. Over the past year, it has dropped by -22.20% (-9.48%). ADIL quarterly ROE is now -110.64% below its all-time high of 2408.70%, reached on 30 September 2017.ADIL Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ADIL ROE Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +67.7% | -9.5% |
| 3 y3 years | +54.1% | +18.8% |
| 5 y5 years | +52.1% | -187.1% |
ADIL ROE High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +77.3% | -39.8% | +30.2% |
| 5 y | 5 years | -4.3% | +77.3% | -187.1% | +30.2% |
| alltime | all time | -130.9% | +77.3% | -110.6% | +92.1% |
Adial Pharmaceuticals ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -256.26%(-12.0%) |
| June 2024 | - | -291.07%(+32.8%) |
| Mar 2024 | - | -219.25%(+19.6%) |
| Dec 2023 | -125.46%(-67.7%) | -183.31%(-21.7%) |
| Sept 2023 | - | -234.06%(+0.9%) |
| June 2023 | - | -231.92%(-17.6%) |
| Mar 2023 | - | -281.52%(+51.2%) |
| Dec 2022 | -388.57%(-29.8%) | -186.17%(-18.2%) |
| Sept 2022 | - | -227.59%(-1.1%) |
| June 2022 | - | -230.17%(-13.7%) |
| Mar 2022 | - | -266.68%(-27.4%) |
| Dec 2021 | -553.72%(+102.6%) | -367.27%(+16.4%) |
| Sept 2021 | - | -315.48%(+5.5%) |
| June 2021 | - | -298.91%(+41.6%) |
| Mar 2021 | - | -211.13%(+23.2%) |
| Dec 2020 | -273.27% | -171.44%(+29.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2020 | - | -132.76%(+27.6%) |
| June 2020 | - | -104.08%(+0.1%) |
| Mar 2020 | - | -104.00%(+14.0%) |
| Dec 2019 | -120.32%(-54.1%) | -91.25%(+2.2%) |
| Sept 2019 | - | -89.26%(-51.3%) |
| June 2019 | - | -183.26%(-34.9%) |
| Mar 2019 | - | -281.40%(-59.1%) |
| Dec 2018 | -261.89%(-329.3%) | -687.24%(-78.8%) |
| Sept 2018 | - | -3235.55%(-1114.9%) |
| June 2018 | - | 318.81%(+37.1%) |
| Mar 2018 | - | 232.53%(-32.1%) |
| Dec 2017 | 114.22%(-71.9%) | 342.67%(-85.8%) |
| Sept 2017 | - | 2408.70%(+94.2%) |
| June 2017 | - | 1240.19%(+171.3%) |
| Mar 2017 | - | 457.20%(+60.6%) |
| Dec 2016 | 405.99% | 284.64% |
FAQ
- What is Adial Pharmaceuticals annual return on equity?
- What is the all time high annual ROE for Adial Pharmaceuticals?
- What is Adial Pharmaceuticals annual ROE year-on-year change?
- What is Adial Pharmaceuticals quarterly return on equity?
- What is the all time high quarterly ROE for Adial Pharmaceuticals?
- What is Adial Pharmaceuticals quarterly ROE year-on-year change?
What is Adial Pharmaceuticals annual return on equity?
The current annual ROE of ADIL is -125.46%
What is the all time high annual ROE for Adial Pharmaceuticals?
Adial Pharmaceuticals all-time high annual return on equity is 405.99%
What is Adial Pharmaceuticals annual ROE year-on-year change?
Over the past year, ADIL annual return on equity has changed by +263.11% (+67.71%)
What is Adial Pharmaceuticals quarterly return on equity?
The current quarterly ROE of ADIL is -256.26%
What is the all time high quarterly ROE for Adial Pharmaceuticals?
Adial Pharmaceuticals all-time high quarterly return on equity is 2408.70%
What is Adial Pharmaceuticals quarterly ROE year-on-year change?
Over the past year, ADIL quarterly return on equity has changed by -22.20% (-9.48%)